†These authors contributed equally to this work.
High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy
Version of Record online: 3 OCT 2011
©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 12, Issue 1, pages 202–209, January 2012
How to Cite
Couzi, L., Helou, S., Bachelet, T., Moreau, K., Martin, S., Morel, D., Lafon, M. E., Boyer, B., Alain, S., Garrigue, I. and Merville, P. (2012), High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy. American Journal of Transplantation, 12: 202–209. doi: 10.1111/j.1600-6143.2011.03766.x
- Issue online: 13 JAN 2012
- Version of Record online: 3 OCT 2011
- Received 06 May 2011, revised 06 July 2011 and accepted for publication 11 July 2011
Table S1: Secondary effects of viral infection
Table S2: Clinical outcome of D+R- patients according to the occurrence of anti-CMV drug resistance
|AJT_3766_sm_SuppMat.doc||39K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.